DevauxLab's profile picture.

Patricia Devaux

@DevauxLab

Patricia Devaux reposted

Efficient and reliable measles reprogramming platform for the generation of human iPSC biorxiv.org/content/10.110… #biorxiv_cellbio


Patricia Devaux reposted

Incredible story that we learned about today at #ASGCT2025!

CHOP & @PennMedicine have delivered the first-ever personalized gene editing therapy for a patient with CPS1 deficiency, marking a major milestone in the application of CRISPR-based treatments. Learn more about KJ & the future of personalized medicine: ms.spr.ly/6015SZLAx.



Patricia Devaux reposted

NIH is centralizing peer review of all applications for grants, cooperative agreements and research and development contracts within the agency’s @CSRpeerreview. This is expected to save NIH more than $65 million annually & make the review process more efficient.…


Patricia Devaux reposted

Very sad to hear this news. Dr. Diane Griffin was an inspirational leader and scientist who was a pioneer in virology. She paved the way for other women to pursue and succeed in science. She will be sorely missed. Her legacy will live on 💐

Mourning the loss of Dr. Diane Griffin, who passed away on Monday. Dr. Griffin was a founding member of @CMM_JHU and chaired our advisory board. A distinguished virologist, she was an elected member of Natl Acad Sci and Natl Acad Med. We remember her with gratitude.

CMM_JHU's tweet image. Mourning the loss of Dr. Diane Griffin, who passed away on Monday. 

Dr. Griffin was a founding member of @CMM_JHU and chaired our advisory board. A distinguished virologist, she was an elected member of Natl Acad Sci and Natl Acad Med. We remember her with gratitude.


Patricia Devaux reposted

In a major milestone for science, for medicine, and for patients, the world’s first CRISPR drug has been approved in the UK. “A new treatment for sickle-cell disease and transfusion-dependent β-thalassemia has been authorised by the Medicines and Healthcare products Regulatory…


Delighted that our paper is finally online for everybody to read! Thanks to everyone who contributed in this work! @ramyarns1 @C_B_Driscoll @ellalee23 and all present and past members of the @DevauxLab!

#MiRNA-mediated control of exogenous OCT4 during mesenchymal-epithelial transition increases measles vector reprogramming efficiency, @MayoClinic researchers reported in @MolTherapy Methods and Clinical Development (#MTM). bit.ly/3lplyGP

MolTherapy's tweet image. #MiRNA-mediated control of exogenous OCT4 during mesenchymal-epithelial transition increases measles vector reprogramming efficiency, @MayoClinic researchers reported in @MolTherapy Methods and Clinical Development (#MTM). bit.ly/3lplyGP


Patricia Devaux reposted

I'm looking for a postdoc to join my lab working on herpesvirus interactions with the cellular DNA damage response. #IHW2021 #ASV2021 Please RT. jobs.mayoclinic.org/jobs/research-…


Loading...

Something went wrong.


Something went wrong.